Targeting BIG3-PHB2 interaction to overcome tamoxifen resistance in breast cancer cells.
Yoshimaru T, Komatsu M, Matsuo T, Chen YA, Murakami Y, Mizuguchi K, Mizohata E, Inoue T, Akiyama M, Yamaguchi R, Imoto S, Miyano S, Miyoshi Y, Sasa M, Nakamura Y, Katagiri T.
Yoshimaru T, et al.
Nat Commun. 2013;4:2443. doi: 10.1038/ncomms3443.
Nat Commun. 2013.
PMID: 24051437
Free PMC article.